Publication | Closed Access
Risankizumab in real life: preliminary results of efficacy and safety in psoriasis during a 16-week period
49
Citations
6
References
2021
Year
16-Week PeriodPsoriatic ArthritisPreliminary ResultsClinical DermatologyReal LifeDermatologySclerodermaMedicine
| Year | Citations | |
|---|---|---|
Page 1
Page 1